Of all the tools in the professional valuer's kit, the Discounted Cash Flow method is the one that demands the most — and reveals the most. It demands rigorous financial modelling, sector knowledge, regulatory understanding, and disciplined assumption-making. In return, it reveals something that no other method can: the intrinsic value of a business — the value anchored not to market sentiment, recent deal activity, or trading multiples, but to the fundamental economic engine of the company itself: its capacity to generate cash.
In India, the DCF method is the cornerstone of the Income Approach under the IBBI Valuation Standards framework, and it is applied by our IBBI-registered valuers across the full spectrum of regulated Valuation assignments — from share issuances under Section 62(1)(b) of the Companies Act, 2013, to ESOP grant-date fair value under Ind AS 102, to FEMA compliance pricing under the FEMA NDI Rules, 2019, to IBC liquidation and going-concern Valuations. For each of these assignments, the DCF model must be constructed with documented, defensible inputs — not opaque assumptions packaged inside a black box.
This guide is designed to demystify every component of the DCF model — from projecting Free Cash Flows and computing the Weighted Average Cost of Capital, through to calculating Terminal Value, bridging from Enterprise Value to per-share Equity Value, and stress-testing the output through sensitivity analysis. Every concept is grounded in Indian regulatory practice, every formula is shown in full, and every step is illustrated through a complete worked numerical example using a fictional Indian specialty chemicals company — presented at the same level of rigour that appears in an IBBI-registered valuer's formal Valuation report.
Key Takeaways:
- DCF is an intrinsic Valuation method — it values a company based on its own projected cash flows, independent of market sentiment or peer trading prices.
- The six-step DCF process — normalise base financials → project FCFs → compute WACC → calculate Terminal Value → discount to PV → bridge to Equity Value — must be executed in sequence with documented rationale at every stage.
- Terminal value typically accounts for 60–80% of total Enterprise Value in a DCF — making the terminal growth rate the single most consequential assumption in the entire model.
- The WACC for Indian unlisted companies combines the risk-free G-Sec yield, beta-adjusted equity risk premium, size premium, and company-specific risk — typically ranging 13–18% depending on sector and capital structure.
- Free Cash Flow to Firm (FCFF) must reflect all reinvestment needs — capex and working capital growth — not just EBITDA; omitting working capital requirements is the most common DCF modelling error.
- A sensitivity analysis across WACC and terminal growth rate is not optional — it validates the single-point Valuation conclusion by demonstrating its robustness across plausible assumption combinations, which is what our team presents in regulatory reports.
- The DCF and CCM methods are complementary — our team uses both and triangulates the outputs; a DCF that diverges significantly from CCM signals either assumption error or a genuine company-specific value driver requiring explanation.
What Is the DCF Valuation Method?
The Discounted Cash Flow method answers one question with mathematical precision: what is a rupee of future cash flow worth today? Because money received in the future is worth less than money received today — due to the time value of money and the risk of not receiving it — every future cash flow must be translated into its present-value equivalent by discounting it at a rate that reflects both the cost of time and the cost of risk. That discount rate is the Weighted Average Cost of Capital (WACC).
The DCF method belongs to the Income Approach — one of three primary Valuation approaches recognised by the IBBI Valuation Standards framework (alongside the Market Approach and the Asset Approach). Its theoretical foundation is that the value of any asset equals the present value of all future cash flows it is expected to generate. A company is therefore worth the sum of the present values of all its future free cash flows — including those beyond the explicit forecast period, captured in the Terminal Value.
DCF in One Equation
Enterprise Value (DCF) = PV of Explicit Period FCFs + PV of Terminal Value
Where: PV = Present Value, discounted at WACC. Explicit period FCFs = projected Free Cash Flows for years 1–5 (or 1–7). Terminal Value = FCF Year N × (1 + g) ÷ (WACC − g), where g = sustainable long-term growth rate. Enterprise Value minus Net Debt equals Equity Value. Equity Value divided by total diluted shares outstanding equals the per-share fair value.
The Six-Step DCF Process — Income Approach
When Is DCF Used in Indian Regulatory Practice?
The DCF method is not merely a financial modelling choice — in India's regulatory Valuation framework, it is a defined requirement across multiple statutory contexts. Understanding when DCF is mandated — and what standards the output must meet — is essential for companies, investors, and finance professionals operating in regulated environments.
| Regulatory Context | Applicable Law | Professional Required | DCF Role |
|---|---|---|---|
| Share Issuance — Further Issue | Section 62(1)(b), Companies Act, 2013 | IBBI-registered valuer (mandatory) | Primary — income approach required alongside market approach |
| ESOP Grant Date Fair Value | Section 62(1)(b); Ind AS 102 | IBBI-registered valuer (mandatory) | Equity value foundation for Black-Scholes / binomial option pricing |
| FEMA — Cross-Border Share Transfer | FEMA NDI Rules, 2019 | IBBI-registered valuer or CA | Primary — internationally accepted method; DCF is explicitly recognised |
| IBC — Insolvency Resolution | Insolvency and Bankruptcy Code, 2016 | IBBI-registered valuer (mandatory) | Going-concern value basis; DCF primary for operational business |
| Scheme of Arrangement — Merger | Sections 230–232, Companies Act, 2013 | IBBI-registered valuer or investment banker | Primary — share exchange ratio determination; DCF + CCM |
| Startup — Section 56(2)(x) / Rule 11UA | Income Tax Act, 1961; Rule 11UA | Merchant Banker or CA | DCF accepted as one of the prescribed methods for startup valuation |
Regulatory Standard: IBBI-registered valuer Valuation reports must comply with the IBBI (Registered Valuers and Valuation) Rules, 2017 and the IBBI Valuation Standards. The Valuation analysis should document: (1) the basis and rationale for the projection period; (2) all key assumptions underlying the FCF projections; (3) the derivation of each component of the WACC; (4) the justification for the terminal growth rate; and (5) the sensitivity of the Valuation to changes in key assumptions. A Valuation report that presents a DCF output without these disclosures does not comply with IBBI standards.
Related regulatory guides: For FEMA compliance pricing where DCF is the primary method for cross-border share transfers, see our complete FEMA Valuation Guide. For SEBI-regulated fairness opinions, delisting determinations, and open offer pricing, see our SEBI Valuation Guide. For startup Valuation under Section 56(2)(x) and Rule 11UA where DCF is one of the prescribed methods, see our Startup Valuation Guide.
How Do You Normalise Base-Year Financials?
The DCF model is only as reliable as the financial foundation on which it is built. Before projecting any future cash flows, the base-year financials — typically the most recent audited annual accounts — must be normalised to represent the company's true, maintainable earning capacity, free from distortions caused by one-time events, accounting policy changes, or non-recurring items.
Normalisation is not optional — it is the step that separates a professional Valuation from a spreadsheet exercise. A company that received a one-time government grant in FY2025, or incurred exceptional restructuring costs, or had a COVID-impacted base year in FY2022, must have these items removed from the starting financials before any projection is built. Failing to normalise means either projecting an inflated starting point (if positive one-time items are included) or an artificially depressed one (if one-time costs are included) — both producing systematically wrong DCF outputs.
Common Normalisation Adjustments for Indian Companies
Pre-Projection Step
Mandatory
Remove from EBIT/EBITDA: exceptional income (insurance claims, asset sale profits, government grants); extraordinary expenses (one-time restructuring, impairment write-offs not expected to recur); COVID-period distortions (unusually low or high revenue from pandemic effects); related-party income or expenses at non-arm's-length pricing (replace with arm's-length equivalent); management remuneration significantly above or below market (normalise to market rate); and capitalised versus expensed R&D differences between years (apply consistent policy). Each adjustment must be documented with the specific amount, source in the financial statements, and rationale for exclusion.
How Do You Project Free Cash Flows Accurately?
Free Cash Flow to Firm (FCFF) is the cash flow available to all capital providers — equity and debt — after the company has met its operating needs and reinvestment requirements. It is the metric that the DCF model discounts. Understanding exactly how FCFF is computed and what drives each of its components is essential to building a credible projection.
Free Cash Flow to Firm (FCFF) — Formula
FCFF = NOPAT + Depreciation & Amortisation − Capital Expenditure − ΔNet Working Capital
WHERE:
NOPAT = EBIT × (1 − Effective Tax Rate) = Net Operating Profit After Tax — the operating profit the company earns if it had no debt (tax-shield excluded).
D&A = Depreciation & Amortisation — a non-cash charge added back (it was deducted to get EBIT but is not a cash outflow).
Capex = Capital expenditure on fixed assets and intangibles (cash outflow). Split into: Maintenance Capex (sustain existing capacity) + Growth Capex (fund new capacity for revenue growth).
ΔNet WC = Increase in Net Working Capital = Increase in (Current Assets − Current Liabilities). Cash consumed by operational expansion (a cash outflow, deducted from FCFF) = Receivables growth + Inventory growth − Payables growth.
Key Insight: A company can show strong EBITDA yet generate low or negative FCFF if it has high capex requirements or rapidly expanding working capital — both of which consume cash that never appears in the P&L.
Building the FCFF projection requires five sub-models working in parallel: a revenue model (growth rate assumptions by product/geography/customer segment); a margin model (EBITDA and EBIT margin trajectory as the business scales); a depreciation schedule (linked to the opening asset base and new capex additions); a capex plan (maintenance vs growth split, consistent with management's stated investment programme); and a working capital model (receivables, inventory, and payables days applied to projected revenue and COGS). All five must be internally consistent — revenue growth that implies margin expansion must also imply working capital growth and supporting capex, or the model is arithmetically incoherent.
■■ Projection Discipline: Never project revenue growth rates that are inconsistent with the sector's total addressable market, the company's historical track record, or its competitive positioning. A specialty chemicals company that has grown at 18% historically cannot be projected at 35% for five years without a specific, documented market opportunity (a new export contract, a greenfield plant, a regulatory tailwind) to justify the acceleration. Our team challenges management projections against sector data, analyst reports, and historical delivery before incorporating them into the DCF model.
How Is WACC Calculated for Indian Companies?
The Weighted Average Cost of Capital is the discount rate applied to FCFF. It represents the blended cost of all financing — equity and debt — weighted by their relative proportions in the company's capital structure, where equity cost reflects risk and debt cost is adjusted for the tax deductibility of interest. Getting the WACC right is as important as getting the cash flow projections right — an error of 1.5% in WACC moves total enterprise value by 15–25% for a typical DCF model.
WACC Formula — Components
WACC = (Cost of Equity × Equity Weight) + (Post-tax Cost of Debt × Debt Weight)
COST OF EQUITY (CAPM + ADDITIONS):
Ke = Rf + β × ERP + SP + CSRP
Rf = Risk-free rate — 10-year G-Sec yield (current market rate as at Valuation date).
β = Relevered Beta — Unlevered peer beta × [1 + (1−T) × (D/E)].
ERP = Equity Risk Premium — India ERP (market risk premium).
SP = Size Premium — Small/mid-cap premium for unlisted companies.
CSRP = Company-Specific Risk Premium — Additional risk for company-level factors (key-person, customer concentration, regulatory exposure).
POST-TAX COST OF DEBT:
Kd (post-tax) = Kd (pre-tax) × (1 − Effective Tax Rate).
CAPITAL STRUCTURE WEIGHTS (USE MARKET VALUE, NOT BOOK VALUE):
Equity Weight = Market Value of Equity ÷ (Market Value of Equity + Total Debt).
Debt Weight = Total Debt ÷ (Market Value of Equity + Total Debt).
WACC Input Benchmarks for Indian Companies (2026)
| WACC Component | Source / Method | Typical Range (India 2026) |
|---|---|---|
| Risk-Free Rate (Rf) | 10-year Government of India security (G-Sec) yield — current market rate as at valuation date (RBI G-Sec data) | 6.8% – 7.2% |
| Equity Risk Premium (ERP) | Damodaran India ERP estimate; or implied ERP from NSE Nifty pricing model; updated annually | 7.0% – 8.5% |
| Beta (β) | Unlevered from 5–8 listed peers; re-levered at subject company's target D/E ratio | 0.55 – 1.30 (sector-dependent) |
| Size Premium (SP) | Duff & Phelps / Kroll size premium study; adjusted for Indian market depth | 1.5% – 3.0% (small/mid-cap) |
| Company-Specific Risk Premium (CSRP) | Management concentration, key-person risk, customer concentration, regulatory risk, track record | 3.0% – 15.0% |
| Pre-tax Cost of Debt (Kd) | Weighted average interest rate on company's current borrowings; verified from financial statements | 8.0% – 12.0% (typically) |
| Tax Rate for Kd adjustment | Effective corporate tax rate: 22% + surcharge + cess = 25.17% (new regime) or 30% + surcharge | 25.17% or ~34.94% |
What Is Terminal Value and How Is It Computed?
Terminal Value (TV) is the value of all free cash flows the company is expected to generate beyond the explicit projection period — captured in a single number using the assumption that, from Year N+1 onwards, FCF grows at a constant, sustainable rate in perpetuity. This is the Gordon Growth Model, and it is the standard method used by IBBI-registered valuers for terminal value computation in Indian DCF reports.
The mathematical consequence of compounding in perpetuity at a steady rate is profound: for most well-constructed DCF models, the terminal value accounts for 60–80% of the total enterprise value. This concentration of value in the terminal value means the terminal growth rate assumption is the most important — and most scrutinised — number in the entire DCF model. A 0.5% increase in the terminal growth rate can increase the total enterprise value by 8–15%, depending on the WACC level.
Terminal Value (TV) is the value of all free cash flows the company is expected to generate beyond the explicit projection period — captured in a single number using the assumption that, from Year N+1 onwards, FCF grows at a constant, sustainable rate in perpetuity. This is the Gordon Growth Model, and it is the standard method used by IBBI-registered valuers for terminal value computation in Indian DCF reports.
The mathematical consequence of compounding in perpetuity at a steady rate is profound: for most well-constructed DCF models, the terminal value accounts for 60–80% of the total enterprise value. This concentration of value in the terminal value means the terminal growth rate assumption is the most important — and most scrutinised — number in the entire DCF model. A 0.5% increase in the terminal growth rate can increase the total enterprise value by 8–15%, depending on the WACC level.
Terminal Value — Gordon Growth Model
Terminal Value (TV) = FCFN × (1 + g) ÷ (WACC − g)
WHERE:
FCFN = Normalised Free Cash Flow in the final year of the explicit period (Year 5 or 7).
g = Sustainable terminal growth rate (long-term perpetuity rate).
WACC = Weighted Average Cost of Capital.
PRESENT VALUE OF TERMINAL VALUE:
PV(TV) = TV ÷ (1 + WACC)N
Mandatory Constraints on 'g':
(1) g must be less than WACC — otherwise the formula produces negative or infinite EV.
(2) g should not exceed India's long-run nominal GDP growth (~11–12%) — no company can sustainably outgrow the entire economy in perpetuity.
(3) Most established Indian companies: 5.0% – 6.5%.
(4) Capital-intensive sectors (infrastructure, mining): 4.0% – 5.5%.
(5) High-growth technology/SaaS: 5.5% – 7.0% (only after normalising to steady-state in the explicit period).
Why Terminal Growth Rate Matters So Much
Consider a company with Year 5 FCF of Rs. 28 crore and WACC of 13.7%. At g = 5.0%: TV = 28 × 1.05 ÷ 0.087 = Rs. 338 crore. At g = 6.0%: TV = 28 × 1.06 ÷ 0.077 = Rs. 386 crore. At g = 6.5%: TV = 28 × 1.065 ÷ 0.072 = Rs. 414 crore. The 1.5 percentage point change in 'g' — from 5.0% to 6.5% — increases the terminal value by Rs. 76 crore, or 22.5%. This is why our team always justifies the terminal growth rate with explicit reference to sector GDP, inflation expectations, and the company's competitive sustainability.
How Does a Full DCF Worked Example Look?
The following complete worked example applies the DCF method to a fictional unlisted Indian specialty chemicals manufacturer. Every number is shown — from normalised base financials through five-year FCF projections, WACC build, terminal value computation, and the full EV-to-Equity bridge — exactly as constructed in an IBBI-registered valuer's formal Valuation report.
📋 Subject Company Profile
ILLUSTRATIVE EXAMPLE
| Parameter | Details |
|---|---|
| Company Name | ABC Speciality Chemicals Private Limited |
| Location | Ahmedabad, Gujarat |
| Business | B2B manufacturer of specialty pigments and performance chemicals for coatings, plastics, and agrochemical formulations — supplying mid-size and large Indian manufacturers and exporting to Southeast Asia |
| Revenue (FY2026 Base) | Rs. 120.0 crore |
| Normalised EBITDA | Rs. 22.8 crore (EBITDA margin: 19.0%) |
| Depreciation & Amortisation | Rs. 5.2 crore |
| Normalised EBIT | Rs. 17.6 crore |
| Effective Tax Rate | 25.17% (new tax regime — Section 115BAA) |
| NOPAT (Base Year) | Rs. 13.2 crore [= 17.6 × (1 − 0.2517)] |
| Capital Expenditure (FY2026) | Rs. 8.0 crore (Rs. 5.0 crore maintenance + Rs. 3.0 crore growth) |
| Net Working Capital (FY2026) | Rs. 28.4 crore (~23.7% of revenue — specialty chemicals norm) |
| Gross Debt | Rs. 35.0 crore (term loans at blended 10.5% per annum) |
| Cash & Equivalents | Rs. 6.5 crore |
| Net Debt | Rs. 28.5 crore |
| Total Diluted Shares | 80,00,000 shares (80 lakh) |
| Valuation Purpose | Section 62(1)(b), Companies Act, 2013 — Strategic investor acquiring minority stake; IBBI-registered valuer report required |
| Valuation Date | 31 March 2026 |
Step 1 — Build the WACC for ABC Chemicals
The WACC is constructed bottom-up, with each component derived from market data as at 31 March 2026. The beta is unlevered from five listed specialty chemicals peers (Sudarshan Chemical, Atul Ltd, Fine Organics, Vinati Organics, Galaxy Surfactants — illustrative) and re-levered at ABC's capital structure.
🔢 WACC Build — ABC Chemicals
ILLUSTRATIVE DATA
| Component | Value | Derivation / Source |
|---|---|---|
| A. COST OF EQUITY (CAPM + Size + CSRP) | ||
| Risk-Free Rate (Rf) | 7.05% | 10-year G-Sec yield as at 31 March 2026 (RBI data) |
| Unlevered Peer Beta (βu) | 0.72 | Median unlevered beta from 5 listed specialty chemicals peers; Hamada unlevering |
| ABC D/E Ratio (at market value) | 0.43x | Net Debt Rs. 28.5 Cr ÷ Equity Value (estimated Rs. 65 Cr pre-DCF) |
| Relevered Beta (βL) | 0.91 | βu × [1 + (1−T) × D/E] = 0.72 × [1 + 0.7483 × 0.43] = 0.72 × 1.322 = 0.951 → rounded 0.91 |
| India Equity Risk Premium (ERP) | 7.50% | Damodaran January 2026 India ERP estimate |
| Size Premium (SP) | 2.00% | Small-cap unlisted company; revenue below Rs. 200 Cr threshold |
| Company-Specific Risk Premium (CSRP) | 1.50% | Customer concentration (top 3 = 42% of revenue); promoter-managed; no external board |
| Cost of Equity (Ke) | 17.38% | = 7.05 + (0.91 × 7.50) + 2.00 + 1.50 = 7.05 + 6.83 + 2.00 + 1.50 |
| B. POST-TAX COST OF DEBT | ||
| Pre-tax Cost of Debt (Kd) | 10.50% | Weighted average interest rate on term loans — verified from Schedule to accounts |
| Effective Tax Rate | 25.17% | New regime — Section 115BAA, Companies Act |
| Post-tax Cost of Debt | 7.86% | = 10.50% × (1 − 0.2517) |
| C. CAPITAL STRUCTURE WEIGHTS (Market Value) | ||
| Total Debt (D) | Rs. 35.0 Cr | Per audited balance sheet — term loans only |
| Equity Value (E) — estimated | Rs. 85.0 Cr | Pre-DCF estimate from CCM cross-check (Rs. 248 crore EV less Rs. 35 debt, adjusted) |
| Total Capital (D + E) | Rs. 120.0 Cr | — |
| Equity Weight (E/V) | 70.8% | 85 ÷ 120 |
| Debt Weight (D/V) | 29.2% | 35 ÷ 120 |
WACC Computation
WACC = (Ke × E/V) + (Kd post-tax × D/V)
= (17.38% × 70.8%) + (7.86% × 29.2%)
= 12.30% + 2.29%
= 14.59% → Rounded to 14.6% for DCF application
WACC — ABC Speciality Chemicals Private Limited 14.6%
Step 2 — Five-Year Free Cash Flow Projections
The five-year projection period is chosen because ABC operates in a moderately cyclical specialty chemicals sector with reasonable management visibility over a 4–5 year horizon. The revenue growth rate starts at 18% in Year 1 — reflecting the company's secured export contracts and domestic market penetration plan — and tapers to 10% by Year 5 as the business approaches a more mature growth phase. EBITDA margins are projected to expand modestly (from 19.0% to 21.5%) as operating leverage from the fixed-cost base takes effect.FCF Projection Model — ABC Speciality Chemicals Pvt. Ltd. |
FCF Projection Model — ABC Speciality Chemicals Pvt. Ltd. | Valuation Date: 31 March 2026
| Line Item (Rs. Crore) | FY2026 Base | FY2027 Year 1 | FY2028 Year 2 | FY2029 Year 3 | FY2030 Year 4 | FY2031 Year 5 |
|---|---|---|---|---|---|---|
| P&L DRIVERS | ||||||
| Revenue Growth Rate | Base | 18.0% | 16.0% | 14.0% | 12.0% | 10.0% |
| Revenue | 120.0 | 141.6 | 164.3 | 187.3 | 209.8 | 230.8 |
| EBITDA Margin | 19.0% | 19.5% | 20.0% | 20.5% | 21.0% | 21.5% |
| EBITDA | 22.8 | 27.6 | 32.9 | 38.4 | 44.1 | 49.6 |
| Depreciation & Amortisation | 5.2 | 5.8 | 6.5 | 7.2 | 7.9 | 8.5 |
| EBIT | 17.6 | 21.8 | 26.4 | 31.2 | 36.2 | 41.1 |
| NOPAT CALCULATION (Tax Rate: 25.17%) | ||||||
| Tax on EBIT | (4.4) | (5.5) | (6.6) | (7.9) | (9.1) | (10.3) |
| NOPAT = EBIT × (1 − 25.17%) | 13.2 | 16.3 | 19.8 | 23.4 | 27.1 | 30.8 |
| FREE CASH FLOW BUILD | ||||||
| Add: Depreciation & Amortisation | +5.2 | +5.8 | +6.5 | +7.2 | +7.9 | +8.5 |
| Less: Capital Expenditure | (8.0) | (10.5) | (10.0) | (9.5) | (8.8) | (8.2) |
| Less: Increase in Net Working Capital | — | (3.8) | (3.4) | (3.5) | (3.4) | (3.2) |
| Free Cash Flow to Firm (FCFF) | 10.4 | 7.8 | 12.9 | 17.6 | 22.8 | 27.9 |
Formula: FCFF = NOPAT + D&A − Capex − ΔNWC | Year 1 lower due to peak growth capex investment phase
Note: Working Capital days held at 87 days receivables / 72 days inventory / 61 days payables throughout the projection — consistent with company's 3-year historical average. Capex tapers from Year 1–2 peak (expansion investment) to Year 4–5 normalised maintenance-plus-growth level. All figures in Rs. Crore.
Step 3 — Terminal Value Computation
The terminal value captures all free cash flows beyond Year 5 (FY2031). At this point, ABC is projected to be a mature specialty chemicals manufacturer, having completed its expansion programme. A terminal growth rate of 5.5% is applied — benchmarked to India's specialty chemicals sector long-run growth, India's nominal GDP consensus, and the company's projected export market share by end of Year 5.
📊 Terminal Value Computation
ILLUSTRATIVE DATA
Gordon Growth Model — Terminal Value
Year 5 Normalised FCFF = Rs. 27.9 Crore
Terminal Growth Rate (g) = 5.5%
WACC = 14.6%
(WACC − g) = 14.6% − 5.5% = 9.1%
Terminal Value (at end of Year 5)
= 27.9 × (1 + 0.055) ÷ 0.091
= 27.9 × 1.055 ÷ 0.091
= 29.43 ÷ 0.091
= Rs. 323.4 Crore
Discount Factor (Year 5)
= 1 ÷ (1 + 0.146)^5
= 1 ÷ (1.146)^5
= 1 ÷ 1.9474
= 0.5135
PV of Terminal Value = 323.4 × 0.5135 = Rs. 166.1 Crore
| Value Component | Amount (Rs. Crore) | % of Total EV |
|---|---|---|
| PV of Year 1–5 FCFs (explicit period) | 56.8 | 25.5% |
| PV of Terminal Value (year 6 onwards) | 166.1 | 74.5% |
| Total Enterprise Value (DCF) | Rs. 222.9 Crore | 100% |
Need a DCF Valuation Report for Your Company?
Our team builds rigorous, fully documented DCF models for Section 62, ESOP, FEMA, IBC, and M&A assignments — pan-India.
How Do You Discount the Cash Flows Step by Step?
With the WACC established at 14.6% and the FCF projections completed, the discounting of each year's free cash flow is a mechanical process — but it must be shown explicitly to allow any reviewer to verify the arithmetic. The discount factor for Year N is simply 1 ÷ (1 + WACC)^N. Each year's FCFF is multiplied by its discount factor to arrive at its Present Value. The terminal value at the end of Year 5 is discounted using the same Year 5 factor.
DCF Discount Schedule — WACC: 14.6% | ABC Speciality Chemicals
| Line Item | FY2027 Year 1 | FY2028 Year 2 | FY2029 Year 3 | FY2030 Year 4 | FY2031 Year 5 | Total |
|---|---|---|---|---|---|---|
| FCFF (Rs. Crore) | 7.8 | 12.9 | 17.6 | 22.8 | 27.9 | — |
| Discount Period (n) | 1 | 2 | 3 | 4 | 5 | — |
| Discount Factor = 1 ÷ (1.146)^n | 0.8726 | 0.7614 | 0.6644 | 0.5799 | 0.5063 | — |
| PV of FCFF (Rs. Crore) | 6.8 | 9.8 | 11.7 | 13.2 | 14.1 | 56.8 ✓ |
| TERMINAL VALUE DISCOUNTING | ||||||
| Terminal Value (end Yr 5) | — | — | — | — | 323.4 | — |
| TV Discount Factor (Year 5) | — | — | — | — | 0.5063 | — |
| PV of Terminal Value (Rs. Crore) | — | — | — | — | 163.8 | 163.8 ✓ |
Note: Slight rounding difference vs. Step 3 (Rs. 166.1 Cr) due to discount factor precision — use 6 decimal places in actual model
ENTERPRISE VALUE = PV(FCFs) + PV(TV) Rs. 220.6 Crore
Discount factors computed as 1 ÷ (1.146)^n at WACC = 14.6%. Year 1: 0.8726; Year 2: 0.7614; Year 3: 0.6644; Year 4: 0.5799; Year 5: 0.5063. EV = Rs. 56.8 + Rs. 163.8 = Rs. 220.6 Crore. Terminal Value = 74.2% of EV — within the expected 60–80% range for a mature-growth company DCF.
Enterprise Value Composition — Value Waterfall
| Enterprise Value Build-Up | Rs. Crore |
|---|---|
| PV of Year 1 FCF (FY2027: Rs. 7.8 Cr discounted) | 6.8 |
| PV of Year 2 FCF (FY2028: Rs. 12.9 Cr discounted) | 9.8 |
| PV of Year 3 FCF (FY2029: Rs. 17.6 Cr discounted) | 11.7 |
| PV of Year 4 FCF (FY2030: Rs. 22.8 Cr discounted) | 13.2 |
| PV of Year 5 FCF (FY2031: Rs. 27.9 Cr discounted) | 14.1 |
| Sub-total: Explicit Period FCFs (Years 1–5) | 55.6 |
| PV of Terminal Value (74.2% of EV) | 163.8 |
Enterprise Value (DCF) — ABC Chemicals Rs. 220.6 Crore
How Does the EV-to-Equity Bridge Work in DCF?
The DCF model produces Enterprise Value — the total value of the business to all capital providers. Equity Value — what the shareholders actually own — is derived by adjusting for the claims of all other capital providers (debt holders) and adding any surplus cash. The bridge from Enterprise Value to Equity Value, and then to per-share value, is identical in structure to the bridge used in CCM Valuation, and must be executed with the same precision.
EV-to-Equity Bridge Formula
Equity Value = Enterprise Value − Gross Debt − Lease Liabilities − Other Debt-Like Items + Cash & Liquid Investments − Contingent Liabilities − Unfunded Obligations
Per-Share Fair Value = Equity Value ÷ Total Diluted Shares Outstanding. The bridge must capture every balance-sheet claim that ranks ahead of equity: term loans, Ind AS 116 lease liabilities, deferred acquisition payments, contingent liabilities (probability-weighted), and unfunded gratuity obligations. Surplus cash and short-term liquid investments are added back because they are not required for operations.
🔗 EV to Equity Value Bridge — ABC Chemicals
ILLUSTRATIVE DATA
| Line Item | Amount (Rs. Crore / per share) |
|---|---|
| Enterprise Value (DCF Output) | Rs. 220.6 Crore |
| Less: Gross Debt — Term Loans | (Rs. 35.0 Crore) |
| Less: Lease Liabilities (Ind AS 116 — operating leases capitalised) | (Rs. 2.3 Crore) |
| Less: Deferred Payment on Plant Acquisition (creditor) | (Rs. 1.8 Crore) |
| Add: Cash & Cash Equivalents | + Rs. 6.5 Crore |
| Add: Short-Term Liquid Investments | + Rs. 1.2 Crore |
| Less: Contingent Liability — Customs Duty Dispute (70% probability) | (Rs. 2.1 Crore) |
| Less: Unfunded Gratuity Liability (actuarial) | (Rs. 1.4 Crore) |
| Equity Value (Controlling Interest, Pre-Discount) | Rs. 185.7 Crore |
| Note: No DLOM or DLOC applied in DCF — illiquidity is embedded in the WACC via the Company-Specific Risk Premium (CSRP) of 1.5% | |
| Total Diluted Shares Outstanding | 80,00,000 shares |
| Fair Value Per Share — DCF (Controlling, Intrinsic) | Rs. 232.1 per share |
DCF vs CCM: Triangulating the Outputs
In the ABC Chemicals example: DCF per-share value = Rs. 232. If the CCM method produced, say, Rs. 245 per share (after applying a 20% DLOM), the divergence is approximately 5.6% — comfortably within the acceptable triangulation range of 10–15%. Our team would arrive at a single-point Valuation conclusion of approximately Rs. 238 per share, derived as a weighted average of both methods (DCF weighted 50%, CCM 50%). The final output is always a single fair value per share — not a range. Where the divergence between DCF and CCM exceeds 20%, the valuer must investigate and explain the source — whether it is an assumption error, a genuine company-specific premium, or a market-pricing anomaly in the comparable set.
What Sensitivity Analysis Should a DCF Include?
A DCF without sensitivity analysis is an incomplete Valuation. The single-point enterprise value output is a mathematical consequence of specific assumptions — and those assumptions carry uncertainty. Presenting only the base-case output implies false precision. our team presents a sensitivity analysis that shows how the Valuation conclusion changes under different combinations of the two most consequential inputs: the WACC and the terminal growth rate.
Sensitivity Matrix — Per-Share Equity Value (Rs.) at Varying WACC and Terminal Growth
| WACC ↓ / Terminal Growth Rate → | 4.5% | 5.0% | 5.5% | 6.0% | 6.5% |
|---|---|---|---|---|---|
| WACC: 12.5% | Rs. 294 | Rs. 312 | Rs. 333 | Rs. 358 | Rs. 388 |
| WACC: 13.5% | Rs. 260 | Rs. 275 | Rs. 291 | Rs. 310 | Rs. 333 |
| WACC: 14.6% ← Base | . 213 | Rs. 222 | Rs. 232 ★ | Rs. 244 | Rs. 258 |
| WACC: 15.5% | Rs. 179 | Rs. 187 | Rs. 196 | Rs. 207 | Rs. 218 |
| WACC: 16.5% | Rs. 152 | Rs. 159 | Rs. 167 | Rs. 176 | Rs. 187 |
Green = High value (favourable assumptions) | Amber = Mid range | Red = Low value | ★ = Base case. All values on a controlling-interest, intrinsic-value basis. Our reports present this table to demonstrate the sensitivity of the Valuation to key assumptions, supporting the single-point conclusion.
The sensitivity matrix reveals that the Valuation for ABC Chemicals ranges from Rs. 152 to Rs. 388 per share across the full range of plausible WACC and terminal growth combinations. The base case — anchored by the WACC of 14.6% and a terminal growth rate of 5.5% — produces a single-point DCF Valuation conclusion of Rs. 232 per share. The sensitivity analysis validates this conclusion by demonstrating that the base-case output falls comfortably within the plausible range, and supports our team's judgement on the final single-point value before triangulating with the CCM output.
How Do You Structure a DCF Model in Excel?
A well-structured DCF Excel model is separated into distinct, logically sequenced worksheets — each with a specific function and clear input/output separation. The architecture described below is the standard used by our team and mirrors the structure of Valuation models used in institutional investment banking and regulatory submissions.
Tab 1 — Cover & Inputss
All modifiable assumptions in one place: company details, Valuation date, projection years, tax rate, D&A policy, capex plan, working capital days (receivables, inventory, payables), terminal growth rate, and WACC components. Colour-code input cells blue. All other tabs reference only this tab — never hard-code assumptions in projection tabs.
Tab 2 — Historical Financials (3–5 years)
Audited P&L, Balance Sheet, and Cash Flow Statement for 3–5 historical years. Include a normalisation schedule showing adjustments to each year's EBITDA and PAT. Compute historical ratios (margin, growth, working capital days, ROCE) that anchor the projection assumptions.
Tab 3 — FCF Projection Model
The core projection tab: Revenue → EBITDA → EBIT → NOPAT → Add D&A → Less Capex → Less ΔNet Working Capital → FCFF for each year of the explicit period. Each line must link to the Inputs tab — never hard-code a projection directly. Include a balance sheet schedule to ensure working capital calculations are grounded in balance sheet logic.
Tab 4 — WACC Build
Dedicated tab for the WACC computation: risk-free rate, beta derivation (with peer beta table), ERP, size premium, CSRP, cost of equity. Debt schedule with blended interest rate. Capital structure at market value. WACC formula linking all components. Output: single WACC cell referenced by the Valuation tab.
Tab 5 — DCF Valuation & Sensitivity
FCFF from Tab 3. Discount factors computed from WACC in Tab 4. PV of each year's FCF. Terminal Value (Gordon Growth). PV of TV. Sum = Enterprise Value. EV-to-Equity bridge (all debt-like and cash-like items). Per-share value. Sensitivity table (Data Table function in Excel — WACC on one axis, terminal growth rate on the other).
Tab 6 — Comparable Company Check (CCM)
Optional but recommended: a parallel CCM computation using listed peer multiples as a cross-check against the DCF output. If both methods are being presented in our Valuation report, this tab provides the full CCM computation alongside the DCF — and a final triangulation schedule showing the weighted average of both methods.
Excel Inputs Tab — Structure and Cell Logic
Tab 1: Inputs & Assumptions — DCF Model Template
| Section / Parameter | Input Value | Notes / Source |
|---|---|---|
| COMPANY DETAILS | ||
| Company Name | ABC Speciality Chemicals Pvt. Ltd. | Text input |
| Valuation Date | 31-Mar-2026 | DATE() cell |
| Projection Period (Years) | 5 | Drives number of FCF columns in Tab 3 |
| REVENUE ASSUMPTIONS | ||
| Base Year Revenue (Rs. Cr) | 120.0 | From normalised FY2026 financials |
| Revenue Growth — Year 1 | 18.0% | Management guidance + order book |
| Revenue Growth — Year 2 | 16.0% | Tapering growth trajectory |
| Revenue Growth — Year 3 | 14.0% | Market share stabilisation |
| Revenue Growth — Year 4 | 12.0% | Organic growth, mature phase entry |
| Revenue Growth — Year 5 | 10.0% | Pre-terminal normalised rate |
| MARGIN & TAX ASSUMPTIONS | ||
| EBITDA Margin — Year 1 → Year 5 | 19.5% → 21.5% | Operating leverage; 5 separate cells |
| Effective Tax Rate | 25.17% | New tax regime — Section 115BAA |
| REINVESTMENT ASSUMPTIONS | ||
| Capex — Year 1 to Year 5 (Rs. Cr) | 10.5 / 10.0 / 9.5 / 8.8 / 8.2 | From management capex plan; 5 cells |
| Receivables Days | 87 days | 3-yr historical average |
| Inventory Days | 72 days | 3-yr historical average |
| Payables Days | 61 days | 3-yr historical average |
| WACC & TERMINAL VALUE | ||
| WACC (from Tab 4) | =WACC!C42 | Links to WACC tab — never hard-code |
| Terminal Growth Rate (g) | 5.5% | Must be less than WACC (14.6%) |
| BALANCE SHEET ADJUSTMENTS (for EV Bridge) | ||
| Gross Debt (Rs. Cr) | 35.0 | From audited balance sheet |
| Lease Liabilities — Ind AS 116 | 2.3 | Schedule of leases — always check this |
| Cash & Liquid Investments | 7.7 | Cash + STI from balance sheet |
| Total Diluted Shares | 80,00,000 | From shareholder register; include ESOPs |
Blue italic cells = user input. All projection tabs reference Inputs tab using absolute cell references ($C$n). The sensitivity Data Table in Tab 5 uses row/column input cells linked to WACC and terminal growth rate inputs above. Never break the reference chain — all changes flow automatically through the model.
What Are the Most Common DCF Errors?
The DCF method's power is also its vulnerability: because every input is an assumption, every input can be engineered — intentionally or inadvertently — to produce a desired output. The following are the errors most frequently identified by our team when reviewing third-party DCF reports, or when stress-testing promoter-prepared Valuation models.
Error 1 — Terminal Growth Rate Above WACC or Sector GDP
Critical Error
Most Common Inflation Driver
Applying a terminal growth rate of 8% when the WACC is 13% may seem mathematically valid (WACC still exceeds g), but it implies the company will grow at 8% in perpetuity — faster than India's estimated long-run nominal GDP growth. No company outgrows the entire economy indefinitely. Where a promoter presents a DCF with g above 7%, our team challenges and documents the justification, or apply a lower rate with disclosed rationale.
Error 2 — Omitting Working Capital in FCF
Critical Error
Overstates FCF by 15–40%
A company growing revenue at 18% annually will need significantly more working capital each year — more inventory, more receivables, partially offset by more payables. If the FCF model shows EBITDA → D&A → Capex but no working capital change, it systematically overstates FCFF. For a specialty chemicals company with 87 days of receivables and 72 days of inventory, an Rs. 21.6 crore revenue increase requires approximately Rs. 3.5–4.0 crore of additional net working capital — cash that is consumed without appearing in the P&L.
Error 3 — Using Book Value Weights in WACC
Common Error
Distorts WACC by 2–5%
WACC must use market value weights for equity and book value (or market value, if traded) for debt. Using book value of equity — which is the historical accumulated accounting entries — instead of the estimated market value of equity produces an incorrect weight ratio. Typically, a company's market value of equity significantly exceeds its book value (P/BV > 1), so using book value understates the equity weight and overstates the debt weight — resulting in a lower WACC and higher enterprise value. This is a systematic overvaluation error.
Error 4 — Projecting Margins Without Justification
Common Error
Projection Credibility
Projecting EBITDA margin expansion from 19% to 26% over five years without specific operational justification — new product mix, plant scale economics, export premium pricing — is not credible and will not survive IBBI scrutiny or counterparty challenge. Every margin assumption must be benchmarked against: (1) the company's own historical margin trajectory; (2) listed peer margins at similar revenue scale; and (3) the specific operational initiatives that will drive the expansion.
Error 5 — Inconsistency Between FCF and Revenue Growth
Critical Error
Internal Model Logic
A DCF that projects 18% revenue growth but uses the same capex as the base year (Rs. 8 crore) is internally incoherent. You cannot grow revenue by 18% in a manufacturing business without investing in additional capacity. The growth capex must be explicitly modelled and proportional to the incremental revenue being generated. A useful cross-check: the reinvestment rate (Capex + ΔNWC − D&A) should be consistent with the sector's capital intensity — for specialty chemicals, approximately Rs. 0.35–0.55 of reinvestment per rupee of incremental revenue.
How Does DCF Compare to the CCM Method?
DCF and CCM are not competing methods — they are complementary lenses on the same underlying value. Each has structural strengths and weaknesses, and our Valuation report uses both, triangulates the outputs, and explains any divergence. Understanding the structural differences helps investors, CFOs, and board members assess which output deserves more weight in a specific transaction context.
| Dimension | DCF Method | CCM Method |
|---|---|---|
| What It Measures | Intrinsic value — based on company's own cash generation | Relative value — based on market pricing of comparable peers |
| Market Sentiment | Independent of current market conditions | Automatically reflects current market sentiment |
| Key Assumption Risk | Terminal growth rate and WACC (60–80% of value in TV) | Peer selection quality and multiple normalisation |
| Best Suited For | Stable cash flow businesses; long projection horizon available | Companies with clear listed peers and positive EBITDA |
| Early-Stage Companies | Difficult — projections highly speculative; TV dominant | Better — EV/Revenue or EV/GMV multiples usable |
| Manipulation Risk | Higher — terminal value engineering is common | Lower — anchored to observable market data |
| IBBI Application | Income Approach — mandatory alongside at least one other method | Market Approach — mandatory alongside at least one other method |
| Negotiation Utility | Useful internally; counterparty will challenge assumptions | Stronger in negotiation — market-based, harder to dispute |
Supporting guides in this cluster: For the full CCM methodology and worked example, see our CCM Valuation Guide. For a pre-investment Valuation checklist, see Valuation Checks Before Investing. For ESOP grant-date fair value Valuation where DCF provides the equity value foundation, see our ESOP Valuation Guide.
Commission a DCF Valuation Report from Elite Valuation
Our IBBI-registered valuers deliver fully documented models and defensible reports for Section 62, FEMA, ESOP, IBC, and M&A mandates — pan-India.
Closing Summary: DCF as a Discipline, Not a Formula
The Discounted Cash Flow method is not a formula — it is a discipline. Its power lies in forcing the valuer to make explicit, quantified judgements about every aspect of a company's future: how fast it will grow, how much it will earn at scale, how much it must reinvest to sustain that growth, and what risk premium the market should require for the uncertainty attached to those judgements. Done with rigour, these judgements produce a Valuation that is transparent, reproducible, and directly traceable to the operational realities of the business. Done carelessly — with engineered assumptions, ignored working capital needs, or unjustified terminal growth rates — DCF becomes the most misleading tool in finance. The ABC Speciality Chemicals worked example in this guide demonstrates the full methodology — from a WACC of 14.6% through five years of FCFF projections, a terminal value of Rs. 323 crore, and a per-share equity value of Rs. 232. This is the standard our team applies to every DCF Valuation mandate — pan-India.
Frequently Asked Questions — Startup Valuation
CA Sagar Shah, Founder
Mr Sagar Shah is the Founder of Elite Valuation and leads the firm’s Valuation and Advisory practice. With over 15+ years of professional experience.
